Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / COM STK CL A
Number of holders
128
Total Shares
99.5M
Shares change
-2.21M
Total reported value, excl. options
$455M
Value change
-$9.01M
Put/Call ratio
0.64
Number of buys
56
Number of sells
-66
Price
$4.57
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.